May 08,2018

Ascensia Diabetes Care Launches Smarter Version of Contour Diabetes App with New Features to Support Self-Management

Ascensia Diabetes Care today announced that it has now launched its upgraded version of the CONTOUR®DIABETES app in 24 countries worldwide. This latest version includes the new My Patterns feature, which uses innovative algorithms to more intelligently analyze blood glucose results received from the CONTOUR®NEXT ONE meter, and delivers personalized meaningful feedback to patients. This feedback is designed to help patients improve diabetes self-management and maintain positive lifestyle changes.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
May 09,2018

Tandem Diabetes Care to Present at the Bank of America Merrill Lynch 2018 Healthcare Conference

Tandem Diabetes Care®, Inc., a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that Kim Blickenstaff, president and CEO, will present a company update at the Bank of America Merrill Lynch 2018 Healthcare Conference, which will be held at the Encore at the Wynn Hotel in Las Vegas, Nevada. The presentation will take place on Tuesday, May 15, 2018 at 12:35 PM Eastern Time (9:35 AM Pacific Time).

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
May 14,2018

Voluntis signs contract with US payer WellDyneRX for coverage of a digital therapeutic

Voluntis, a company specialized in digital therapeutics, and WellDyneRx, a full-service, independent pharmacy benefit manager (PBM), announced today that Voluntis’ Insulia® will be incorporated into the recently-launched WellManaged-Diabetes program. This innovative, patient-centered program uses a high touch model often seen in traditional specialty pharmacy for high cost medications and expands its application to better serve WellDyneRx members with diabetes.

COLLABORATION PARTNERSHIP

#product & service

#dtx

View Analyst & Ambassador Comments
Go to original news
May 15,2018

Nemaura Medical to Present at the UBS Global Healthcare Conference

Nemaura Medical Inc., a medical technology company developing the wireless sugarBEAT® non-invasive glucose monitoring system for adjunctive use by persons with diabetes, today announced that Chief Business Officer, Bashir Timol, will be presenting at the UBS Global Healthcare Conference, being held May 21-23, 2018 in New York.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
May 15,2018

DarioHealth Reports First Quarter 2018 Results

DarioHealth Corp., a leading global digital health company with mobile health and big data solutions, today reported financial and operational results for the first quarter ended on March 31, 2018. The Company's revenue for the first quarter ended March 31, 2018 was $1,756,000, a 74% increase from $1,007,000 in first quarter ended March 31, 2017, and an 11.3% increase sequentially from the fourth quarter of 2017.

View Analyst & Ambassador Comments
Go to original news
May 21,2018

DarioHealth to Present at Chardan's Digital Health Conference

DarioHealth Corp., a leading global digital health company with mobile health and big data solutions, today announced that Erez Raphael, Chairman and CEO of DarioHealth, will be delivering a presentation at Chardan's Digital Health Conference, on May 22, 2018 at 1:45 PM PDT.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
May 29,2018

Insulet to Present at Upcoming Investor Conference

Insulet Corporation, the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at the William Blair & Company 38th Annual Growth Stock Conference in Chicago, IL on Tuesday, June 12, 2018 at 12:50 p.m. (Central Time).

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
May 29,2018

Voluntis successfully completes its IPO and raises €30.1M on the regulated market of Euronext in Paris

Voluntis, a company specialized in digital therapeutics, today announces the success of its initial public offering in Compartment C of Euronext’s regulated market in Paris. The IPO, which was structured as a global offer (the “Offer”), consisting of a public offering in France in the form of an open-price offer (“OPO”) and a global placement chiefly intended for institutional investors in France and some other countries (the “Global Placement”), raised €30.1m through a capital increase. The price applicable to the Global Placement and the OPO was set at €14.0per share, representing the bottom of the Offer’s tightened indicative price range, as announced in the Company’s press release dated May 28, 2018.

View Analyst & Ambassador Comments
Go to original news
May 30,2018

Nemaura Medical Signs Joint Collaboration Agreement for European Commercialization

Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing the wireless sugarBEAT® non-invasive glucose monitoring system for adjunctive use by persons with diabetes, today announced that it has entered in to a definitive joint Collaboration Agreement with Dallas Burston Ethitronix (DBE) to commercialize sugarBEAT® in the European Economic Area (EEA).

COLLABORATION PARTNERSHIP

#institution

#cgm

View Analyst & Ambassador Comments
Go to original news
Jun 14,2018

Beurer writes a digital success story

Digitization is a mega trend that is now spreading through all industries. The Association of German Chambers of Industry and Commerce (DIHK) and regional Chambers of Industry and Commerce (IHKs) were looking for digital success stories in the German corporate world for the second time. Beurer was once again able to impress and was named the nationwide winner in the "E-Health" category.

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES